Identifying factors affecting recurrence and survival after rectal cancer surgery
Predictors of Disease Free Survival After Curative Cancer Rectum Surgery
This study looks at past patients who had surgery for rectal cancer to see what factors might affect their chances of the cancer coming back and how long they stay cancer-free afterwards.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | South Valley University Academic / other |
| Locations | 1 site (Qinā) |
| Trial ID | NCT06096493 on ClinicalTrials.gov |
What this trial studies
This observational study conducts a retrospective analysis of patients who underwent curative surgical resection for rectal cancer. It aims to identify various prognostic factors that influence the likelihood of cancer recurrence and the duration of disease-free survival post-surgery. Data will be collected from patient files, including demographics, histopathological details, and follow-up outcomes. The study will exclude patients with specific conditions and those who lost follow-up to ensure accurate results.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone curative surgery for rectal cancer.
Not a fit: Patients with familial adenomatous polyposis, multiple rectal cancers, or those who died within three months post-surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify key factors that predict recurrence, potentially guiding more effective post-surgical care for rectal cancer patients.
How similar studies have performed: Other studies have explored prognostic factors in rectal cancer, indicating that this approach has been previously validated in the field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who had curative surgery for cancer rectum. Exclusion Criteria: * Patients with familial adenomatous polyposis (FAP), multiple synchronous or metachronous rectal cancers, and death within 3 months * Patients that lost follow-up will be excluded.
Where this trial is running
Qinā
- Qena Faculty of Medicine, South Valley University Hospitals — Qinā, Egypt (Recruiting)
Study contacts
- Principal investigator: Abdallah M Taha, MD — South Valley University, Egypt.
- Study coordinator: Abdallah M Taha, MD
- Email: abdallahsurgery@med.svu.edu.eg
- Phone: +201011716497
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.